FEBRILE NEUTROPENIA AND AVAILABLE BIOMARKERS AMONG CHILDREN WITH HEMATOLOGICAL MALIGNANCIES

被引：0
|
作者：
Garcia-Espinoza, A. [1 ]
Figueroa-Carbajal, J. [1 ]
机构：
[1] Inst Mexicano Seguro Social, Mexico City, DF, Mexico
来源：
PEDIATRIC BLOOD & CANCER | 2013年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：234 / 235
页数：2
相关论文
共 50 条
  • [1] FEBRILE NEUTROPENIA AND AVAILABLE BIOMARKERS AMONG CHILDREN WITH HEMATOLOGICAL MALIGNANCIES
    Kourti, M.
    Iosifidis, I.
    Slavakis, A.
    Geladari, A.
    Goumberi, S.
    Roilides, E.
    Koliouskas, D.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 234 - 234
  • [2] FEBRILE NEUTROPENIA EPISODES AND EVALUATION OF AVAILABLE BIOMARKERS AMONG CHILDREN WITH HEMATOLOGICAL MALIGNANCIES
    Kourti, M.
    Iosifidis, I.
    Slavakis, A.
    Sidi, V.
    Geladari, A.
    Goumberi, S.
    Koliouskas, D.
    Roilides, E.
    HAEMATOLOGICA, 2013, 98 : 723 - 723
  • [3] GARENOXACIN PROPHYLAXIS FOR FEBRILE NEUTROPENIA AFTER CHEMOTHERAPY IN HEMATOLOGICAL MALIGNANCIES
    Nakamura, N.
    Tsurumi, H.
    Shibata, Y.
    Mabuchi, R.
    Kitagawa, J.
    Suetsugu, A.
    Kanemura, N.
    Goto, N.
    Hara, T.
    Moriwaki, H.
    ANNALS OF ONCOLOGY, 2013, 24 : 47 - 47
  • [4] Efficacy and safety of micafungin for treating febrile neutropenia in hematological malignancies
    Goto, Naoe
    Hara, Takeshi
    Tsurumi, Hisashi
    Ogawa, Kengo
    Kitagawa, Junichi
    Kanemura, Nobuhiro
    Kasahara, Senji
    Yamada, Toshiki
    Shimizu, Masahito
    Nakamura, Mitsuhiro
    Matsuura, Katsuhiko
    Moriwaki, Hisataka
    AMERICAN JOURNAL OF HEMATOLOGY, 2010, 85 (11) : 872 - 876
  • [5] Mortality in patients with hematological malignancies, febrile neutropenia, and septic shock
    Islas-Munoz, Beda
    Volkow-Fernandez, Patricia
    Silva-Zamora, Jorge
    Ramirez-Ibarguen, Ana
    Cornejo-Juarez, Patricia
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2024, 18 (02): : 235 - 242
  • [6] A general chemotherapy myelotoxicity score to predict febrile neutropenia in hematological malignancies
    Moreau, M.
    Klastersky, J.
    Schwarzbold, A.
    Muanza, F.
    Georgala, A.
    Aoun, M.
    Loizidou, A.
    Barette, M.
    Costantini, S.
    Delmelle, M.
    Dubreucq, L.
    Vekemans, M.
    Ferrant, A.
    Bron, D.
    Paesmans, M.
    ANNALS OF ONCOLOGY, 2009, 20 (03) : 513 - 519
  • [7] Secondary Infections in Febrile Neutropenia in Hematological Malignancies: More Than Another Febrile Neutropenic Episode
    Demirel, Ashhan
    Tabak, Fehmi
    Ar, M. Cem
    Mete, Bilgul
    Ongoren, Seniz
    Yemisen, Mucahit
    Ozaras, Resat
    Eskazan, Emre
    Baslar, Zafer
    Mert, Ali
    Soysal, Teoman
    Ferhanoglu, Burhan
    Aydin, Yildiz
    Ozturk, Recep
    TURKISH JOURNAL OF HEMATOLOGY, 2015, 32 (03) : 243 - 250
  • [8] Biomarkers for risk stratification of febrile neutropenia among children with malignancy: A pilot study
    Mian, Amir
    Becton, David
    Saylors, Robert
    James, Laura
    Tang, Xinyu
    Bhutta, Adnan
    Prodhan, Parthak
    PEDIATRIC BLOOD & CANCER, 2012, 59 (02) : 238 - 245
  • [9] FEBRILE NEUTROPENIA IN HEMATOLOGICAL PATIENT
    Jose Angel, Raposo Puglia
    Vahi Sofia, Ordonez
    Cuenca Araceli, Salamanca
    Sanchez Vicente, Rubio
    Chacon Eusebio, Martin
    Maria Dolores, Madrigal Toscano
    Lopez Sebastian, Garzon
    HAEMATOLOGICA, 2016, 101 : 372 - 372
  • [10] Aminoglycosides' dosage in hematological malignancies and febrile neutropenia: extended interval or conventional dosage?
    Cabrera Figueroa, S. E.
    Vasquez Remolcoy, D. A.
    Cisterna Castillo, P. A.
    Fissore Troncoso, G. C.
    PERSONALIZED MEDICINE, 2023, 20 (01) : 5 - 11
12345